GQJENBURKT Jenburkt Pharmaceuticals. Ltd. os Oc: 9, Jaypakash Road Ando (Wes, arb - 409058. Phone 02267608608 Fax 0-22 66013127 Ref. No. PLICS/140572016 Date:22" October, 2016. To BSE LU. roe Fexjecbhoy Towers, Dalal Suet, ‘Mumbai - 400 001, ‘Reg: Regulation 30 2) of SEBI (Listing Obligations and Disclosure Requirements) ‘Regulation, 2015, Subs today, us. 22" October, 2016 — Results for ee aaa aig nee ots — Ra ke Dea Sir, ‘indy note tha the Audit Committe have reviewed and the Board of Directors ofthe ‘Compaay have approved the unaudied financial results forthe quarter ended cn 30° ‘September, 2016 cing ther respective meetings held ods, Le on 22™ October, 2016, ‘The unaudited financial results ofthe Company fr the quarter from 1 July, 2016 0 30% Septembsr, 2016 duly signed inthe format specified under clause 30 (4 of SEBI (Listing ‘Obligations and Disebsure Requirements) Regulation, 2015, i enclosed. ‘Also enclosed slong with is the limited audit review report of the Auuitrs of the Company, on the Unaodited Financial Results forthe quarter ended on 30" September, 2016 Kindly take on recordthe above and acknowledge. “Thanking you, ‘Yours fithily, [PB Jenburkt Pharmaceuticals La, ° * oe ° ° {#8 Science hal toh Hope hai 3 Hope hai toh Health hai ¢@ Health hai toh Happiness hai # 2 En eetntcan ‘cm ‘On Wo. Laz HEL ONES *EXJENBURKT Jenburkt Pharmaceuticals Ltd. gd Oc: 95, taypatac Raed, dhe (Wosh Muna 400058. Phone: 02-67 60860 Fa 91 2-00848127 ‘Statement of Stndolone.Unaudid Finch Ress forthe Quarter and Sk Months Ended on 30/09/2016 TT ang JOT arg orto sae] sete Pee mons | Site | Mom Lent | eestor | Pens eo sora oar] ora [apsrais| aT Wensie [Unused | Unseied | Unuated [Ursus | — uct lr fons om Opes Taft sone fom Operas ie sai] | —_samnsi| ese soe (ifr Sprang eae "Zai| 73h sai[ isso] noo] er [stalin rom Operant a ci sai] maar] —— ral —easosa| aise] aa fr —ferenses Teer narra Comaned iar] sas | aaa so] a {efron enti of Fad Goods Nom InopesrandStckntrace 1905] __vess]_ ss60x] 99200833] azo (linsoyer berets Sasi] —sieei| 50933] its] oss] rea, {fe epecsion on rotator EOE ea 673] ase —szaal 358 foutesonse zoo] —ass0se] 20053] —aanoal — esa] —— rok Prot am apc blo arn ane sts ang exept ers 2) soo] 2079] _a782s|__s7oso]_rosss|_ ats ret ran orang aero arn aaa Keeton tame) nos) 2099] sys] wor] ours] va een ens 56) sous] ama] ssoan|__omzas|__ sonnel __ssnoat. fetal tons as| 12a oo] —s3a0]— 09 Te pt cn cay aie as asa] — aot] 33039] —o9s0s] sons) aaa ft et Prof ron scary oie sere 0) 0a00] —anaas] sansa ears] saan] sor i ier forts onto] — woes] asa] sors] — soa] anv ft ssn equty store ant. Ra a5tsa| —aeussl tensa] sea] nota] 4a fs — essere cg eatin Reserves DN Fees er Share itr envoy rae Ta segs Share er evan ens-F Meg. He ie Stn Pc an chores ot cape Oec neem * ® ¥e ‘# Science hai toh Hope hai 3 Hope hai toh Health hai @ Health hai toh Happiness hai # * Ema: nba “OWN No, L242GXYJENBURKT Jenburkt Pharmaceuticals La, os Ot, Jypakath Roa, dw (Wed), Mania A00 058. Pane: 0224769 ena Fax 91-22 80003127 oe ‘eine! ‘an! nas Ee YE rh Poa zy {sane tor i fo en born za zal Ppesearenuaie a a [Se Toma = wal ma a3 ‘a | ea so ‘earetecusetnconnay ter pete meen elon? 102016 2 Tecan eel nce phrases tnsegnen eesepren eo ofl alee 2 The teoeofpo yearend aang whee ee Peso maa * er at egX s Sree Geman, OF o ‘ Science hai toh Hope hai 3 Hope hai toh Health hai @ Health hai toh Happiness hai # a Ena ogi ‘wpm Cane zee 3KOX Dilip. 1. Arora D.L.ARORA & Co. ‘com (tons), Fo CHARTERED ACCOUNTANTS LIMITED REVIEW REPORT TO THE, BOARD OF DIRECTORS OF JENBURKT PHARMACEUTICALS LIMITED, 10 THE BOARD OF DIRECTORS, JENBURKT PHARMACEUTICALS LIMITED, Mas \We bave reviewed the accompanying statement oF unaudited statement of fnaneal result of Jenburkt Pharmaceuticals Limited ("ho company"), forthe quar ended on September 302016 (“the statement) bing submited by the Company. pursuant othe requirement of Regulation 33 ofthe SEDI ‘Cistng Obligations and Disosare Requvsmeat) Regulations, 2015 a5 modified by crear no. | CIRVCFDIPACIG22016 dated July 5, 2016 This statement is the responsibly of the Company's Management sd has been approved by the Board of Directors. Our responsiblity ss a epot on these inns statements based on ou review. ‘We conducted our review in accordance with the Standard on Review Engagements (SRE) 2410 , “Review of nei Financial fformaton erormed ty the Independent Auditor ofthe Et issued by the Insite of Chattred Accountants of India. This Standard requis that we plan and perform the review to obtain modemte asurace at to whether tho financial statements are free of material Imistatement. A review is limied primarily to inguirsof company personnel and analytical procedures ‘pple to financial data and ts provide lest assrace than an aut, We have not performed an aut fn accordingly, we do not express an aut opinion Based on ou review conducted as above, nothing has come to ou tention thst eases us to believe that the acconpaying statement of Unaudited fsncial results prepared in accordance with applicable ‘ccountng sanders and ther recognized secounting practices and policies has not disclosed the information sequred to be dstosed in tem of Regulation 33 of the SEBI( Listing Obligations and (Disclosure Regulements) Regaatons, 2015 a8 modified by creular no. CIRICFD/FACIG22016 dated July 5, 2016, inching the manner in which i i o be disclosed, or dat it contains any matcal F For Aren & Co sep. Che Acoma GP enn onsasw fs (ucwaensin) ” el =) &O ™ BI ti re Plast: Mumba : Propstor Duc 22/102016 Mos 036152 EiMy Documents -IenbuLimited review repotsep/2016, 9/4285, Bhagyodaya, Kher Nagar, Banda (Bast), Mumba 400 051 [Contact #91-022 2687 0541/6550 6222/2647 4719 Emailaroradi19S6@gmaiLcom, aroradl@redifinalcom